恶性血液病侵袭性真菌感染的研究进展  

Advance in Study on Invasive Fungal Infection Secondary to Hematological Malignancy

作　　者：刘林辉[1] 付美兰[1] 

机构地区：[1]新疆医科大学,新疆乌鲁木齐市830054

出　　处：《中国全科医学》2009年第2期163-165,共3页Chinese General Practice

摘　　要：恶性血液病继发侵袭性真菌感染(invasive fungal infections,IFI),病情重,病死率高,成为患者病情加重乃至死亡的主要原因之一。研究恶性血液病患者合并IFI的特点,做到早期诊断,及时处理危险因素,预防性应用抗真菌药物,合理选用有效抗真菌药物,对减少真菌感染的发生,延长恶性血液病患者的生存期有重要作用。现将近年来的研究进展进行综述。Invasive Fungal Infection(IFI)secondary to Hematological Malignancy(HM) is a disease with severe nosocomial infection and high mortality,causing aggravation of primary disease or even leading to death.Research of the characterics of IFI in HM,early diagnosis,prevention of its risk factors,prophylactic application of anti-fungus medicines,reasonable choice of effetive anti-fungus medicines should be carried out,thus to decrease the incidence of IFI and to prolong the survival of patients with HM.This review ...

关 键 词：血液肿瘤 真菌血症 治疗 

分 类 号：R733[医药卫生—肿瘤]